Articles

Export this record

Export selected records

Export record to excel

File type to download

Beta version

Record title

MEL-18 loss mediates estrogen receptor-α downregulation and hormone independence

Record identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4463188

MEL-18 loss mediates estrogen receptor-α downregulation and hormone independence

ACCESS
https://collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4463188

MEL-18 loss mediates estrogen receptor-α downregulation and hormone independence

Full title

MEL-18 loss mediates estrogen receptor-α downregulation and hormone independence

Publisher

United States: American Society for Clinical Investigation

Journal title

The Journal of clinical investigation, 2015, Vol.125 (5), p.1801-1814

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4463188

Language

English

Formats

Publication information

Publisher

Subjects

Subjects and topics

Aminopyridines - administration & dosage Animals Antineoplastic Agents, Hormonal - pharmacology Antineoplastic Agents, Hormonal - therapeutic use Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biomarkers, Tumor - biosynthesis Biomarkers, Tumor - genetics Breast Neoplasms - drug therapy Breast Neoplasms - metabolism Breast Neoplasms - mortality Breast Neoplasms - pathology Carcinoma, Ductal, Breast - drug therapy Carcinoma, Ductal, Breast - metabolism Carcinoma, Ductal, Breast - mortality Carcinoma, Ductal, Breast - pathology Cysteine Endopeptidases Drug Resistance, Neoplasm Endocrinology Endopeptidases - metabolism Estrogen Receptor alpha - analysis Estrogen Receptor alpha - biosynthesis Estrogen Receptor alpha - genetics Estrogens Female Humans Kaplan-Meier Estimate Mice Morpholines - administration & dosage Neoplasm Proteins - deficiency Neoplasm Proteins - genetics Neoplasm Proteins - physiology Neoplasm Transplantation Neoplasms, Hormone-Dependent - drug therapy Neoplasms, Hormone-Dependent - metabolism Neoplasms, Hormone-Dependent - mortality Neoplasms, Hormone-Dependent - pathology Oncology Polycomb Repressive Complex 1 - deficiency Polycomb Repressive Complex 1 - genetics Polycomb Repressive Complex 1 - physiology Progesterone Proportional Hazards Models Proteasome Endopeptidase Complex - metabolism Protein Processing, Post-Translational - drug effects Receptor, ErbB-2 - analysis Receptors, Progesterone - analysis Receptors, Progesterone - biosynthesis Receptors, Progesterone - genetics RNA, Messenger - biosynthesis RNA, Messenger - genetics RNA, Neoplasm - biosynthesis RNA, Neoplasm - genetics Sp1 Transcription Factor - metabolism Sumoylation - drug effects Tamoxifen - administration & dosage Tamoxifen - pharmacology Tamoxifen - therapeutic use Triple Negative Breast Neoplasms - drug therapy Triple Negative Breast Neoplasms - metabolism Triple Negative Breast Neoplasms - mortality Triple Negative Breast Neoplasms - pathology Tumor Suppressor Protein p53 - metabolism

More information

SCOPE AND CONTENTS

Contents

ALTERNATIVE TITLES

Full title

Identifiers

PRIMARY IDENTIFIERS

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4463188

Permalink

https://collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4463188

OTHER IDENTIFIERS

ISSN

E-ISSN

DOI

How to access this item

Online

1 item

How to access?

Login with a Library card